Correspondence and General Collaboration Papers 1996

CA2 licensing papers, meeting administration, Centocor annual reports, T14 data, T22 protocol, clinical trial results meetings documents and correspondence relating to relations between the Kennedy Institute and Centocor for the continuation of cA2 trials.

See SA/KET/A/2/1 for an overview of the Centocor correspondence, general papers and list of main correspondence contributors.

See SA/KET/A/1 for papers on Centocor sponsored clinical studies/trials.

Item contains some duplicate correspondence.

1996

1 file (in 3 parts)

This item is held in offsite storage and requires a longer time for delivery. This item is also restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2057.